Read on Twitter
1/ When the coronavirus hit, thousands of researchers dropped their previous work and began working on a solution to the pandemic instead.
@edyong209 examines the good and the bad aspects of this extraordinary moment for science. https://www.theatlantic.com/magazine/archive/2021/01/science-covid-19-manhattan-project/617262/
@edyong209 examines the good and the bad aspects of this extraordinary moment for science. https://www.theatlantic.com/magazine/archive/2021/01/science-covid-19-manhattan-project/617262/
2/ As scientists turned their attention to the virus, new possibilities for fast research emerged—including vaccine development.
The virus was fully sequenced in January 2020. “And now in the fall, we’re finishing ... a Phase 3 trial,” Anthony Fauci told Yong. “Holy mackerel.”
The virus was fully sequenced in January 2020. “And now in the fall, we’re finishing ... a Phase 3 trial,” Anthony Fauci told Yong. “Holy mackerel.”
3/ “The secrets [SARS‑CoV‑2] yields will deepen our understanding of other viruses, leaving the world better prepared to face the next pandemic,” Yong argues. “But the COVID‑19 pivot has also revealed the all-too-human frailties of the scientific enterprise.”
4/ Flawed research made the pandemic more confusing. Clinicians wasted millions of dollars on sloppy trials. Overconfident poseurs published misleading work. Racial and gender inequalities in the scientific field widened.
5/ “COVID-19 has already changed science immensely, but if scientists are savvy, the most profound pivot is still to come—a grand reimagining of what medicine should be,” Yong writes.
6/6 “The scientific community spent the pre-pandemic years designing faster ways of doing experiments, sharing data, and developing vaccines” @edyong209 concludes. “Its goal now should be to address its many lingering weaknesses.” https://www.theatlantic.com/magazine/archive/2021/01/science-covid-19-manhattan-project/617262/
